Ovarian Epithelial Carcinoma clinical trials at UC Irvine

1 in progress, 0 open to eligible people

Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression
Sorry, in progress, not accepting new patients
The primary objectives of this study are to observe the safety and tolerability of bemarituzumab and to evaluate preliminary antitumor activity.
Orange 5379513, California 5332921 and other locations

Last updated: July 23, 2025